Marijuana Legalization by State 2026

Edmund Murphy
Dr. Jenni Jacobsen
Written by Edmund Murphy on 23 August 2021
Medically reviewed by Dr. Jenni Jacobsen on 14 October 2026

The legal status of marijuana is changing rapidly throughout the country, which can make it confusing to know exactly what is legal and where. Our index informs you exactly where marijuana is legal and in what context as of September, 2026.

Status

Hover or tap a state for details.

Updated legislation - June 2026

On December 18, 2025, U.S. President Donald Trump issued an executive order directing the DEA and HHS to pursue the reclassification of marijuana as a Schedule III substance. Although the order did not bring about an immediate change in drug policy or legislation, it is expected to lead to a reduction in cannabis’s scheduling status in the near future.

As of September 2nd 2026, 41 states, three territories, and the District of Columbia allow medical cannabis products. 24 states also allow non-medical use, and 7 have updated their medical use policies to include "low THC, high cannabidiol" products, which is explained below.

Low-THC update

The eight states listed under CBD/Low-THC Program in the table below allow the use of these products for medical reasons in limited circumstances or as a legal defence. These "Low-THC Programs" are not designated as comprehensive medical cannabis programs. This has raised issues amongst regulatory bodies when trying to define exactly what "comprehensive" entails, with the NCSL currently using the following criteria.

  1. Protection from criminal penalties for using cannabis for a medical purpose.
  2. Access to cannabis through home cultivation, dispensaries, or some other system is likely to be implemented.
  3. It allows a variety of strains or products, including those with more than "low THC."
  4. It allows either smoking or vaporization of some kind of cannabis products, plant material, or extract.
  5. It is not a limited trial program.

The growing popularity of legalized marijuana

Less than 15 years ago, marijuana use was illegal throughout the United States. With the growing application and popularity of medicinal marijuana as a means of treating chronic pain conditions and other medical concerns, the substance is now legal for medicinal use in 41 states. It is fully legal for use in 24 states and the District of Columbia, and is decriminalized in an additional seven states.

Over this time, there has been a steep increase in the amount of marijuana use in the United States, with marijuana being the third highest type of substance abuse after tobacco and alcohol. In 2021, 11% of young adults reported using marijuana daily, compared to 6% in 2011.

Medicinal marijuana has been able to help people manage painful conditions, like arthritis and cancer, and it has also contributed to economic growth. In 2022, there was a 33% increase in marijuana-related jobs created within one year, with over 100,000 new jobs created since 2021.  Additionally, the worth of the legal marijuana industry was estimated at $33.6 billion in 2023 and is expected to reach over $76 billion by 2030.

On April 23, 2026, the Department of Justice and the Drug Enforcement Administration (DEA) announced that two categories of marijuana had been moved from Schedule I to Schedule III of the Controlled Substances Act: FDA-approved drug products containing marijuana, and marijuana products covered by a state medical marijuana license. This formally recognizes that medical marijuana has an accepted medical use, but it does not legalize or decriminalize marijuana under federal law.

Recreational marijuana remains in Schedule I, even in states where it is legal, and the April order is currently being challenged in federal court. A separate DEA hearing on rescheduling all marijuana took place in June and July 2026, but it has not yet produced a final decision.

Marijuana legalization continues to change across the country. Below is an up-to-date list (as of October 2025) of marijuana's legal status, including whether it is legal for adult use, legal for medicinal purposes, or decriminalized (no jail penalty and reduced fines for possession).

(In this chart, CBD oil refers to oil made with small amounts of THC).

StateLegal for Recreational UseLegal for Medicinal UseDecriminalizedCBD/Low-THC Program
AlabamaNoYesNoNo
AlaskaYesYesYesNo
ArizonaYesYesYesNo
ArkansasNoYesNoNo
CaliforniaYesYesYesNo
ColoradoYesYesYesNo
ConnecticutYesYesYesNo
DelawareYesYesYesNo
District of ColumbiaYesYesYesNo
FloridaNoYesNoNo
GeorgiaNoYesNoNo
HawaiiNoYesYesNo
IdahoNoNoNoNo
IllinoisYesYesYesNo
IndianaNoCBD Oil OnlyNoYes
IowaNoCBD Oil OnlyNoYes
KansasNoNoNoNo
KentuckyNoYesNoNo
LouisianaNoYesYesNo
MaineYesYesYesNo
MarylandYesYesYesNo
MassachusettsYesYesYesNo
MichiganYesYesYesNo
MinnesotaYesYesYesNo
MississippiNoYesYesNo
MissouriYesYesYesNo
MontanaYesYesYesNo
NebraskaNoYesYesNo
NevadaYesYesYesNo
New HampshireNoYesYesNo
New JerseyYesYesYesNo
New MexicoYesYesYesNo
New YorkYesYesYesNo
North CarolinaNoNoYesYes
North DakotaNoYesYesNo
OhioYesYesYesNo
OklahomaNoYesNoNo
OregonYesYesYesNo
PennsylvaniaNoYesNoNo
Rhode IslandYesYesYesNo
South CarolinaNoNoNoYes
South DakotaNoYesNoNo
TennesseeNoCBD Oil OnlyNoYes
TexasNoYesNoNo
UtahNoYesNoNo
VermontYesYesYesNo
VirginiaYesYesYesNo
WashingtonYesYesYesNo
West VirginiaNoYesNoNo
WisconsinNoCBD Oil OnlyNoYes
WyomingNoCBD Oil OnlyNoYes

All information has been sourced from The Marijuana Policy Project (MPP) and is up to date as of October 31st, 2025. This article is informational and does not constitute legal advice, and no guarantees are made regarding its accuracy or completeness.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Johnston, M. (Updated 2024). U.S. Marijuana Laws by State. Britannica. Retrieved from
  2. National Institutes of Health. (2022). Marijuana and Hallucinogen Use Among Young Adults Reached All-Time High in 2021. NIH. Retrieved from
  3. Barcott, B., & Whitney, B. (2022). The US Cannabis Industry Now Supports 428,059 Jobs. Leafly. Retrieved from
  4. Grand View Research. (2023). U.S. Cannabis Market Size, Share & Trends Analysis Report By Source (Hemp, Marijuana), By Derivatives (CBD, THC), By End-use (Medical Use, Recreational Use), By Cultivation (Indoor, Outdoor), And Segment Forecasts, 2024 – 2030. Retrieved from
  5. Miller, Z., Goodman, J., Mustian, J., & Whitehurst, L. (Updated 2024). US Poised to Ease Restrictions on Marijuana in Historic Shift, But it’ll Remain Controlled Substance. AP News. Retrieved from
  6. DISA. (Updated 2024). Marijuana Legality by State. Retrieved from
  7. Amin, M. R., & Ali, D. W. (2019). Pharmacology of Medical Cannabis. Advances in experimental medicine and biology, 1162, 151–165. Retrieved from
  8. Gabay M. (2013). The federal controlled substances act: schedules and pharmacy registration. Hospital pharmacy, 48(6), 473–474.
  9. National Conference of State Legislatures. (2026, September 2). State medical cannabis laws. Retrieved September 8, 2026, from
  10. Trump, D. J. (2025, December 18). Increasing medical marijuana and cannabidiol research (Executive Order No. 14370). The White House.
  11. Ohio State University. (2026). Federal Marijuana Rescheduling: Process and Impact.
  12. U.S. Department of Justice. (2026, April 23). Justice Department places FDA-approved marijuana products and products containing marijuana subject to a qualifying state-issued license in Schedule III, strengthening medical research while maintaining strict federal controls [Press release].
  13. Pennsylvania Medical Society. (2026, April 30). Feds reschedule approved marijuana products to Schedule III. PAMED.
  14. Ropes & Gray. (2026, June). Clearing the haze: Federal marijuana rescheduling heads to DEA hearing as legal challenges loom.
  15. Morgan Lewis. (2026, September 24). Post–DEA hearing, broader marijuana rescheduling questions remain.

Activity History - Last updated: 14 October 2026, Published date:


Reviewer

Dr. Jenni Jacobsen has a PhD in psychology, and she teaches courses on mental health and addiction at the university level and has written content on mental health and addiction for over 10 years.

Activity History - Medically Reviewed on 30 June 2021 and last checked on 14 October 2026

Medically reviewed by
Dr. Jenni Jacobsen

Dr. Jenni Jacobsen

PhD

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

Related topics